Article
Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916.
Infection and immunity - 1 Sept 1990
Watson D A, Musher D M
Abstract excerpt
Transposon Tn916 mutagenesis was used to produce mutant strains of Streptococcus pneumoniae serotype 3 that lacked only a polysaccharide capsule. Southern blotting, DNA-DNA hybridization, and immunochemical analyses demonstrated that the presence of a single copy of Tn916 was sufficient to produce unencapsulation. The 50% lethal dose for such mutants was greater than 5 x 10(7) CFU, as opposed to a 50% lethal dose...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
